首页>
外国专利>
A NOVEL MODIFIED RELEASE PHARMACEUTICAL COMPOSITION OF SITAGLIPTIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
A NOVEL MODIFIED RELEASE PHARMACEUTICAL COMPOSITION OF SITAGLIPTIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
展开▼
机译:西格列汀或其药学上可接受的盐的新型修饰的药物组成
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a novel modified release pharmaceutical composition of sitagliptin or pharmaceutically acceptable salt thereof. In particular the present invention relates to a novel modified release composition of sitagliptin or pharmaceutically acceptable salt thereof that achieves desired minimum effective plasma concentration of the sitagliptin sufficient for effective glycemic control in patients with type 2 diabetes mellitus. A method of improving glycemic control in adults with type 2 diabetes mellitus and reducing or eliminating fluctuations in plasma concentration of sitagliptin is also provided by the present invention.
展开▼